Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
37.8%
% of IDNA's 49 holdings also in BBP
27.9%
% of BBP's 65 holdings also in IDNA
Overlap by Weight
Sector Drift (IDNA minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IDNA |
Weight in BBP |
Overlap | |
---|---|---|---|---|
LIGAND PHARMACEUTICALS-CL B | 2.4% | 1.9% | 1.9% | |
GILEAD SCIENCES INC | 5.7% | 1.8% | 1.8% | |
SAREPTA THERAPEUTICS INC | 4.3% | 1.7% | 1.7% | |
BIOCRYST PHARMACEUTICALS INC | 1.6% | 1.8% | 1.6% | |
INCYTE CORP | 5.0% | 1.6% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
IDNA Overweight Relative to BBP
REVOLUTION MEDICINES, INC. | 5.7% | |
BEIGENE, LTD. | 5.4% | |
EXELIXIS INC | 5.1% | |
ROCHE HOLDING LTD | 4.3% | |
TAKEDA PHARMACEUTICAL CO LTD | 4.0% | |
SANOFI-AVENTIS | 4.0% | |
GILEAD SCIENCES INC | 3.9% | |
ARCELLX, INC. | 3.9% | |
INCYTE CORP | 3.4% | |
BIONTECH SE SPONSORED ADR | 3.4% |
IDNA Underweight Relative to BBP
MIRUM PHARMACEUTICALS, INC. | -2.4% | |
ALNYLAM PHARMACEUTICALS INC | -2.1% | |
TRAVERE THERAPEUTICS, INC. | -2.0% | |
LEXICON PHARMACEUTICALS, INC. | -1.9% | |
LEGEND BIOTECH CORPORATION SPONSORED | -1.9% | |
ACADIA PHARMACEUTICALS INC | -1.9% | |
IONIS PHARMACEUTICALS, INC. | -1.8% | |
DAY ONE BIOPHARMACEUTICALS, INC. | -1.8% | |
TG THERAPEUTICS INC | -1.8% | |
ADMA BIOLOGICS, INC. | -1.8% |